Lose Weight, Gain Huge Debt: NY Provider Has Sued More Than 300 Patients Who Had Bariatric Surgery
By Fred Schulte
April 20, 2023
KFF Health News Original
The private equity-backed practice has been known to demand more than $100,000 in charges or penalties. One patient is fighting back.
Payback: Tracking the Opioid Settlement Cash
April 20, 2023
Page
Featured Story Lookup tool of payouts Table of state councils Map of Opioid Settlement Cash Localize The Data If you are a journalist who wants to investigate opioid settlement transparency data for your area, here’s how you can do that. Share Your Settlement Story Do you have concerns about how your state or locality is […]
Perspectives: Mifepristone Is Life Saving; Making Naloxone OTC Will Make It More Impactful
April 19, 2023
Morning Briefing
Read recent commentaries about pharmaceutical and drug-cost issues.
New Combination Drugs Prove Successful Against Severe Covid; FDA Approves Quilipta For Migraines
April 19, 2023
Morning Briefing
Read about the biggest pharmaceutical developments from the past week.
MedPAC Recommends Congress Lower Payments For Post-Acute Care
April 19, 2023
Morning Briefing
The Medicare Payment Advisory Commission’s recommendation applies to all post-acute care settings except long-term care hospitals and also asks Congress to look at adopting smaller site-neutral policies. News outlets cover AI in health care, a “smart” hospital’s 5G network, and more.
Texas Leads US In Dementia Mortalities
April 19, 2023
Morning Briefing
A report in the Houston Chronicle covers data from the Seniorly Resource Center which shows Texas has the greatest dementia burden score in the country, highlighting a lack of support given to patients’ loved ones. Also: “tranq,” magic mushrooms, gender-affirming care bans, and more.
Study Finds Up To 1 In 4 Students Misusing ADHD Drugs
April 19, 2023
Morning Briefing
Taking ADHD drugs without prescriptions or for non-medical reasons may be becoming a widespread situation among middle and high school students, NBC News reports. Meanwhile, a different report shows about 1 in 4 Americans may be living with air pollution that can harm their health.
Eisai-Biogen Alzheimer’s Drug Shows No Net Health Benefit: Study
April 19, 2023
Morning Briefing
A new report says lecanemab, a new Alzheimer’s drug from Eisai and Biogen, doesn’t show a net health benefit over current drugs, and at its current price isn’t long-term value for the money. Meanwhile, Mark Cuban’s drug company, aimed at lowering prices, is setting up its own pharmacy network.
Biden Signs Executive Order To Boost Long-Term Care, Child Care
April 19, 2023
Morning Briefing
Reuters notes President Joe Biden is facing congressional “resistance” to his care economy proposals. The new executive order aims to advance free preschool and expand affordable care for children, older Americans, and those with disabilities. It also tackles working conditions for care workers.
Number Of Applicants For OB-GYN Residencies Falls 5.2%
April 19, 2023
Morning Briefing
The drop in applicants more than doubled in 13 states with abortion bans, according to the Association of American Medical Colleges. Because many doctors practice medicine where they complete their residency, health experts say they are worried about the future of reproductive care in restrictive states.
Supreme Court Could Rule Today On Whether To Allow Abortion Pill Limits
April 19, 2023
Morning Briefing
Justices will decide whether to let stand an earlier decision from the 5th Circuit Court of Appeals that restricted the use of mifepristone. Legal experts are pointing out the irony of today’s ruling: Justices demanded last year that states decide abortion issues for themselves, yet now the high court is exerting control again.
HHS Making Plans To Get Uninsured Free Covid Vaccines, Treatments, And Tests
April 19, 2023
Morning Briefing
The Biden administration is expected to release the initiative this week, Politico reports, to keep tools for combatting covid free through 2024 for those who are uninsured. Other pandemic news covers vaccine mandates and new virus research.
FDA Approves Second Updated Covid Booster For Some At High Risk
April 19, 2023
Morning Briefing
Among its efforts to simplify covid vaccine guidance, the FDA backed an additional dose of the bivalent covid shot for people 65 and over or those who are immunocompromised. The boosters could be administered as soon as the CDC clears the change.
Morning Briefing for Wednesday, April 19, 2023
April 19, 2023
Morning Briefing
Covid boosters, mifepristone, OB-GYN residents, telehealth, long-term care, Alzheimer’s, drugs costs, and more are in the news.
First Edition: April 19, 2023
April 19, 2023
Morning Briefing
Today’s early morning highlights from the major news organizations.
California’s Medicaid Experiment Spends Money to Save Money — And Help the Homeless
By Angela Hart
April 19, 2023
KFF Health News Original
Gov. Gavin Newsom’s ambitious experiment in health care is supposed to cut costs as it fills the needs of hard-to-reach people. The program’s start is chaotic and limited, but it shows promise.
The CDC Lacks a Rural Focus. Researchers Hope a Newly Funded Office Will Help.
By Christina Saint Louis
April 19, 2023
KFF Health News Original
Advocates for improving rural health pushed for the CDC to extend its rural health focus by creating an Office of Rural Health. They hope the agency will commit to rural health research and provide analyses that lead to good public health policies for rural communities.
Redes sociales alimentan obsesión por las drogas para bajar de peso, sin hablar de riesgos
By Darius Tahir and Hannah Norman
April 18, 2023
KFF Health News Original
La competencia para hacerse con un mercado que podría valer $100.000 millones al año, solo para los fabricantes de medicamentos, ha desencadenado una ola de publicidad que preocupa a las autoridades sanitarias y médicos de todo el mundo.